chr9-27109640-C-G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_000459.5(TEK):āc.50C>Gā(p.Ser17Cys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000539 in 1,614,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000459.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TEK | NM_000459.5 | c.50C>G | p.Ser17Cys | missense_variant, splice_region_variant | 1/23 | ENST00000380036.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TEK | ENST00000380036.10 | c.50C>G | p.Ser17Cys | missense_variant, splice_region_variant | 1/23 | 1 | NM_000459.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251200Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135788
GnomAD4 exome AF: 0.0000280 AC: 41AN: 1461848Hom.: 0 Cov.: 30 AF XY: 0.0000261 AC XY: 19AN XY: 727228
GnomAD4 genome AF: 0.000302 AC: 46AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74420
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.50C>G (p.S17C) alteration is located in exon 1 (coding exon 1) of the TEK gene. This alteration results from a C to G substitution at nucleotide position 50, causing the serine (S) at amino acid position 17 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at